The Japan regenerative medicine market reached USD 7.6 billion in 2023 and is projected to grow at a CAGR of 11.7%, reaching USD 23.1 billion by 2032. The market growth is fueled by rising concerns over transplant rejection, increasing demand for regenerative orthopedic therapies, a growing emphasis on dental regeneration, and the expanding use of regenerative medicine in wound healing. https://www.imarcgroup.com/japan-regenerative-medicine-market